Can a website curb overprescribing of addictive anxiety pills?
NCT ID NCT07379073
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving doctors access to a special website can help them follow guidelines for prescribing benzodiazepines (medicines for anxiety and sleep). About 100 general practitioners in France will either get the website or continue as usual. Researchers will check prescription records to see if the website leads to shorter, safer treatment durations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Training intervention with access to a clinical support website (PsychoMG)
- What this could lead to
- If successful, this could give doctors a simple online tool to reduce risky long-term benzodiazepine use.
- What could go wrong
- This is a small, early-stage study in one French region. The website may not change prescribing habits, or results may not apply elsewhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENZODIAZEPINE USE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.